These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7365015)

  • 1. Diatrizoate distribution in dogs as a function of administration rate and time following intravenous injection.
    Ono N; Martinez CR; Fara JW; Hodges FL
    J Comput Assist Tomogr; 1980 Apr; 4(2):174-7. PubMed ID: 7365015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Absorption, excretion and distribution of amikacin following intravenous drip infusion. Intravenous drip infusion, one shot intravenous injection and intramuscular administration of amikacin in dogs, rabbits and rats].
    Matsumoto H; Ochiai K; Nakajima A; Matsuzaki M
    Jpn J Antibiot; 1982 Aug; 35(8):2034-46. PubMed ID: 7154249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impermeability of the blood-brain barrier to intravenous high-iodine-dose meglumine diatrizoate in the normal dog.
    Hayman LA; Pagani JJ; Serur JR; Hinck VC
    AJNR Am J Neuroradiol; 1984; 5(4):409-11. PubMed ID: 6205572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):291-5. PubMed ID: 6600346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diatrizoate levels in cerebrospinal fluid following intravenous administration. Role of fluid production rate.
    Harnish PP; Northington FK; Samuel KA
    Invest Radiol; 1988 May; 23(5):377-80. PubMed ID: 3384618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-density evaluation of the liver after iosulamide meglumine: a tissue-specific CT contrast agent.
    Marincek B; Young SW; Enzmann DR
    Invest Radiol; 1982; 17(1):90-4. PubMed ID: 7076441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous bolus of 125I labeled meglumine diatrizoate. Early extravascular distribution.
    Dean PB; Kormano M
    Acta Radiol Diagn (Stockh); 1977 May; 18(3):293-304. PubMed ID: 899855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the drip infusion and bolus techniques in excretory urography as a routine examination.
    Claypool HR; Lind TA; Haber K; Freundlich IM
    Ariz Med; 1975 Aug; 32(7):552-5. PubMed ID: 1147788
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). IV. Intramuscular, intravenous and drip intravenous administration of HAPA-B in dogs].
    Serizawa K; Shirai M; Endo S; Suzuki T; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):220-31. PubMed ID: 3586331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravenous sodium diatrizoate on the function of the transplanted canine kidney.
    DeWolf WC; Kim ES; Arora VK; Shafer RB; Miller J
    Invest Radiol; 1977; 12(1):81-4. PubMed ID: 320153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT evaluation of suspected hepatic metastases: comparison of techniques for i.v. contrast enhancement.
    Paushter DM; Zeman RK; Scheibler ML; Choyke PL; Jaffe MH; Clark LR
    AJR Am J Roentgenol; 1989 Feb; 152(2):267-71. PubMed ID: 2783503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous contrast bolus in computed tomography investigation of mass lesion.
    Love L; Malone A; Churchill R; Reynes C; Moncada R; Demos T; Salinas M
    Diagn Imaging Clin Med; 1984; 53(2):57-66. PubMed ID: 6561119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inequality of clearance values obtained by intravenous bolus and by steady-state infusion. Prednisolone studies in dogs.
    Frey FJ; Frey BM
    Pharmacology; 1982; 24(6):346-54. PubMed ID: 7111375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
    Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
    J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iosulamide: a new intravenous cholangiocholecystographic medium.
    Rosenberg FJ; Ackerman JH; Nickel AR
    Invest Radiol; 1980; 15(6 Suppl):S142-7. PubMed ID: 6782035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of myocardial contrast enhancement: an in vivo computed-tomographic study.
    Cipriano PR; Nassi M; Brody WR
    Radiology; 1981 Sep; 140(3):823-6. PubMed ID: 7280253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new animal model for testing renal tolerance of contrast agents.
    Krause W; Gilles T
    Invest Radiol; 2003 Nov; 38(11):704-11. PubMed ID: 14566180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study on nephrotoxicity of ionic and non-ionic contrast agents for drip infused urography].
    Sugaya K; Nishizawa O; Noto H; Suzuki T; Shimoda N; Miyagata S; Harada T; Tsuchida S
    Hinyokika Kiyo; 1992 Jul; 38(7):767-73. PubMed ID: 1524001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of aztreonam into pleural exudate following rapid intravenous bolus or constant infusion.
    Miglioli PA; Pivetta P; Fantoni U; Nodari F
    Chemotherapy; 1990; 36(5):321-4. PubMed ID: 2209165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast enhancement in abdominal CT: bolus vs. infusion.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1981 Aug; 137(2):351-8. PubMed ID: 6789645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.